Research progress and development potential of oncolytic vaccinia virus
Abstract. Oncolytic virotherapy is a promising therapeutic approach treating tumors, where oncolytic viruses (OVs) can selectively infect and lyse tumor cells through replication, while also triggering long-lasting anti-tumor immune responses. Vaccinia virus (VV) has emerged as a leading candidate f...
Saved in:
| Main Authors: | Xinyu Zhang, Jiangshan He, Yiming Shao, Sihan Zhou, Xiuyuan Hao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer
2025-04-01
|
| Series: | Chinese Medical Journal |
| Online Access: | http://journals.lww.com/10.1097/CM9.0000000000003585 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances of oncolytic vaccinia viruses armed with interleukin in tumor therapy
by: Mingyong Zha, et al.
Published: (2025-05-01) -
Novel oncolytic vaccinia virus armed with interleukin-27 is a potential therapeutic agent for the treatment of murine pancreatic cancer
by: Bing Han, et al.
Published: (2025-05-01) -
Current status and research progress of oncolytic virus
by: Yingyu Chen, et al.
Published: (2024-12-01) -
Oncolytic vaccinia virus delivering tethered IL-12 enhances antitumor effects with improved safety
by: David L Bartlett, et al.
Published: (2020-05-01) -
Dose Considerations for Vaccinia Oncolytic Virus Based on Retrospective Reanalysis of Early and Late Clinical Trials
by: Mefotse Saha Cyrelle Ornella, et al.
Published: (2024-09-01)